We are live on ! Find out more
CC

Capital Counsel Portfolio holdings

AUM $2.35B
1-Year Est. Return 21.34%
This Fund
S&P 500
This Quarter Est. Return
+2.15%
1 Year Est. Return
+21.34%
3 Year Est. Return
+69.88%
5 Year Est. Return
+102.01%
10 Year Est. Return
+473.12%
AUM
$967M
AUM Growth
-$153M
Cap. Flow
-$158M
Cap. Flow %
-16.35%
Top 10 Hldgs %
74.54%
Holding
61
New
Increased
7
Reduced
19
Closed
4

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$32.8M
2
ECL icon
Ecolab
ECL
+$3.45M
3
RHT
Red Hat Inc
RHT
+$595K
4
XOM icon
ExxonMobil
XOM
+$369K
5
CME icon
CME Group
CME
+$357K

Sector Composition

Rank Sector Weight
1 Healthcare 34.97%
2 Financials 17.08%
3 Technology 14.04%
4 Industrials 10.34%
5 Communication Services 4.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CME icon
1
CME Group
CME
$93.5B
$102M 10.56%
885,625
+3,208
+0.4% +$357K
ADP icon
2
Automatic Data Processing
ADP
$106B
$101M 10.48%
985,603
-20,696
-2% -$1.93M
MTD icon
3
Mettler-Toledo International
MTD
$28.1B
$98M 10.13%
234,139
-5,083
-2% -$2.12M
ESRX
4
DELISTED
Express Scripts Holding Company
ESRX
$94.9M 9.82%
1,379,980
-172,236
-11% -$12.3M
IDXX icon
5
Idexx Laboratories
IDXX
$44.9B
$92.3M 9.54%
786,956
-28,982
-4% -$3.31M
WAB icon
6
Wabtec
WAB
$51.7B
$68M 7.03%
818,778
-13,585
-2% -$1.12M
V icon
7
Visa
V
$697B
$61.2M 6.33%
784,830
-6,014
-0.8% -$483K
RHT
8
DELISTED
Red Hat Inc
RHT
$39.1M 4.04%
560,713
+7,705
+1% +$595K
JNJ icon
9
Johnson & Johnson
JNJ
$643B
$34.5M 3.56%
299,199
+284,217
+1,897% +$32.8M
VAR
10
DELISTED
Varian Medical Systems, Inc.
VAR
$29.4M 3.04%
373,028
-9,328
-2% -$755K
INTC icon
11
Intel
INTC
$435B
$27.3M 2.82%
751,498
-4,800
-0.6% -$172K
ECL icon
12
Ecolab
ECL
$79.6B
$25M 2.58%
212,909
+29,454
+16% +$3.45M
AL
13
DELISTED
Air Lease Corp
AL
$20.5M 2.12%
596,165
-171,169
-22% -$5.63M
SHY icon
14
iShares 1-3 Year Treasury Bond ETF
SHY
$25.4B
$15.3M 1.58%
180,690
-1,479,960
-89% -$125M
CLB icon
15
Core Laboratories
CLB
$493M
$15.2M 1.57%
126,446
+2,368
+2% +$262K
XOM icon
16
ExxonMobil
XOM
$634B
$12.4M 1.29%
137,785
+4,221
+3% +$369K
KO icon
17
Coca-Cola
KO
$380B
$7.24M 0.75%
174,729
GILD icon
18
Gilead Sciences
GILD
$167B
$6M 0.62%
83,756
MRK icon
19
Merck
MRK
$326B
$5.91M 0.61%
105,152
MMM icon
20
3M
MMM
$94.1B
$4.85M 0.5%
32,456
CHRW icon
21
C.H. Robinson
CHRW
$20B
$4.75M 0.49%
64,900
DHR icon
22
Danaher
DHR
$140B
$3.66M 0.38%
52,988
AAPL icon
23
Apple
AAPL
$4.99T
$3.38M 0.35%
116,704
XLNX
24
DELISTED
Xilinx Inc
XLNX
$2.9M 0.3%
48,000
SM icon
25
SM Energy
SM
$7.11B
$2.53M 0.26%
73,300
-9,800
-12% -$354K

Similar funds

Capital Counsel's Q4 2016 Portfolio in Review

As of Q4 2016, Capital Counsel held 61 positions worth $967M, down 14% from $1.12B the previous quarter. Its ten largest holdings account for 75% of the portfolio.

Capital Counsel withdrew a net $158M in Q4 2016, closing 4 positions and reducing 19 holdings. Its most notable exit was Jefferies Financial Group, an estimated $390K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Capital Counsel added an estimated $32.8M to Johnson & Johnson.

  • Capital Counsel added most to Johnson & Johnson in Q4 2016, an estimated $32.8M increase.
  • Capital Counsel's biggest Q4 2016 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $125M.
  • Capital Counsel fully exited Jefferies Financial Group in Q4 2016, selling an estimated $390K.
  • Capital Counsel's ten largest holdings make up 75% of its $967M portfolio in Q4 2016.
  • Capital Counsel opened 0 new positions and closed 4 in Q4 2016.
  • Capital Counsel's portfolio value fell 14% quarter-over-quarter to $967M.

Based on Capital Counsel's 13F filing for Q4 2016, filed 13 Feb 2017.